Ironwood Pharmaceuticals Financing
Ironwood Pharmaceuticals Inc, Corporation just had published form D about $150.00 million debt financing. This is a new filing. Ironwood Pharmaceuticals was able to finance itself with $150.00 million. That is 100.00% of the fundraising. The total financing amount was $150.00 million. The financing document was filed on 2016-10-11. The reason for the financing was: unspecified.
Ironwood Pharmaceuticals is based in Massachusetts. The filler’s business is Pharmaceuticals. The form D was filed by HALLEY E GILBERT SENIOR VICE PRESIDENT, CHIEF LEGAL OFFICER, AND SECRETARY. The company was incorporated more than five years ago. The filler’s address is: 301 Binney Street, Cambridge, Ma, Massachusetts, 02142. Peter M. Hecht is the related person in the form and it has address: C/O Ironwood Pharmaceuticals, Inc., 301 Binney Street, Cambridge, Ma, Massachusetts, 02142. Link to Ironwood Pharmaceuticals Filing: 000144684716000001.
Analysis of Ironwood Pharmaceuticals Offering
On average, companies in the Pharmaceuticals sector, sell 60.90% of the total offering size. Ironwood Pharmaceuticals sold 100.00% of the offering. Could this mean that the trust in Ironwood Pharmaceuticals is high? The average offering size for companies in the Pharmaceuticals industry is $556,000. The total amount raised is 26,878.42% bigger than the average for companies in the Pharmaceuticals sector. The minimum investment for this offering is set at $0. If you know more about the reasons for the financing, please comment below.
What is Form D? What It Is Used For
Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.
Why Fundraising Reporting Is Good For Ironwood Pharmaceuticals Also
The Form D signed by HALLEY E GILBERT might help Ironwood Pharmaceuticals Inc’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.